OL投稿流程

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

OL投稿流程

去美国化学会主页申请一个帐号(暗码切切不要忘记)

第二:

进入投稿体系

上载投稿信,文章(OL有规定的摸板),支撑材料(必定要有元素分析哦,没有的话,高分辨质谱可以代替)

投稿信(这是我的仅供参考)

Dear Editors and Referees:

The ************* is a useful method for the production of *************** which are important pharmaceutical intermediates. It is known that the ***************** has been achieved with excellent enantioselectivity. In sharp contrast, the use of ********************* has been proven much more challenging. As a result, few **** have been reported to ******************. ********* reported a *************************with moderate yields and enantioselectivities. However, the ****************** is substantially less effective for ***** substrates. In the same year, ***** and his co-workers described the ************ in the presence of *************** with high enantioselectivities and yields. Subsequently, ************ and our group have reported*************. Although the advances have been achieved, ************, *************, or other ********** must be employed. Here, we reported a efficient system for *****************.

a) This is the first example of highly efficient********* which could **********************.

b) Our ******** employs no additional ************ or the **************. This has greatly simplified the experimental procedure for this reaction.

We would like to submit the manuscript to Org. Lett (communication) for publication. It would be highly appreciated if you give a favorable consideration on it.

Sincerely yours,

第三:

文章投出

体系答复:

>Dear Dr.:

Your manuscript

Manuscript Title: ****************************************was received in the editorial offices of Organic Letters on 10-MAR-05.

Thank you for submitting your work to Organic Letters.

Submission of a manuscript to Organic Letters implies that the work reported

therein has not received prior publication and is not under consideration for

publication elsewhere in any medium, including electronic journals and computer

databases of a public nature. This manuscript is being considered with the

understanding it is submitted on an exclusive basis. If otherwise, please advise.

When your manuscript has been assigned an editor, you will receive a second email

containing the fax number or mailing address to which you should send your

copyright form.

If you submitted this manuscript as the Corresponding Author, you may find it

convenient to share your security key. The security key allows one other person

to submit a revision to the manuscript and/or track the manuscript's status on

their own Paragon home page.

If the manuscript was submitted on your behalf, its status does not currently

display on your Paragon home page. Use the security key to add this manuscript to

your Paragon home page.

Please remember that only the Corresponding Author and one other person may track

a manuscript's status at one time.

Sincerely,

Editor-in-Chief, Organic Letter

一般第二天就会给你分主编,你可以进你的投稿主页上看到分派给你的主编.

这时,你的进美国化学会下载版权,签名后(主如果第一作者和通信作者)发往分派给你的主编.这一点很重要,因为你不发版权,主编就不会给你送审稿人!!!!!!

第四

假如你在审稿时代经由过程体系跟踪你的文章

会有以下答复:

This email is to inform you that the person who is tracking your manuscript "************************************************", ************has changed. Previously it was being tracked by *****. Effective immediately it is being

tracked by *****.

Please remember that only two people, the Corresponding Author and one other

person, may track a manuscript at one time. If you choose to share your

manuscript number and security key with additional parties for the purpose of

tracking, the newer party will overwrite any previous person who was tracking the manuscript. New parties will not overwrite your ability to track your

manuscript.

没有关系,意思是说只许可你和通信作者跟踪文章

第五:

文章有消息(一般一个月)

Dear Prof.***:

Your paper has been reviewed and I would be happy to accept it after

the attached reviewer comments and the items indicated on the revision

相关文档
最新文档